State-of-the-art: low vision rehabilitation.

The State of the Art is strong - to paraphrase another famous saying. Low vision rehabilitation (LVR) is today a recognized discipline in Ophthalmology, expanding and improving the quality of life of numerous visually impaired patients. It was not so about a century ago when it all started. Then, charity work aimed at helping blind children was all that LVR was. With advances in science, medicine and public health policy, help for the blind expanded its reach to all who were visually impaired. Devices and re-training of skills have been added to complement diagnosis and charity work. Modern LVR, which took hold in the last few decades, was propelled to new heights by relentless advances in basic and clinical sciences. Today we can provide significant and meaningful help to visually impaired patients in most situations. It could be as simple as a hand magnifier or as intricate as a retinal prosthesis. In many instances it seems to be just a beginning for things still to come.

[1]  Patricia Grant,et al.  Reading rehabilitation of individuals with AMD: relative effectiveness of training approaches. , 2011, Investigative ophthalmology & visual science.

[2]  S. Markowitz,et al.  Principles of modern low vision rehabilitation. , 2006, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[3]  G T Plant,et al.  A work out for hemianopia , 2004, British Journal of Ophthalmology.

[4]  Michael Larsen,et al.  Incidence of legal blindness from age-related macular degeneration in denmark: year 2000 to 2010. , 2012, American journal of ophthalmology.

[5]  Kevin P. Moloney,et al.  Reorganization of visual processing is related to eccentric viewing in patients with macular degeneration. , 2008, Restorative neurology and neuroscience.

[6]  M. Mainster.  Violet and blue light blocking intraocular lenses: photoprotection versus photoreception , 2006, British Journal of Ophthalmology.

[7]  R. Schuchard,et al.  Preferred retinal loci relationship to macular scotomas in a low-vision population. , 1997, Ophthalmology.

[8]  Frederik J Potgieter,et al.  Safety and efficacy of an intraocular Fresnel prism intraocular lens in patients with advanced macular disease: Initial clinical experience , 2014, Journal of cataract and refractive surgery.

[9]  A. Chetrit,et al.  Time trends in the incidence and causes of blindness in Israel. , 2012, American journal of ophthalmology.

[10]  Mark Michels,et al.  Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. , 2009, Ophthalmology.

[11]  W. Feinbloom.  INTRODUCTION TO THE PRINCIPLES AND PRACTICE OF SUB-NORMAL VISION CORRECTION , 1935 .

[12]  Ian L Bailey,et al.  The Berkeley Rudimentary Vision Test , 2012, Optometry and vision science : official publication of the American Academy of Optometry.

[13]  A. Cruess,et al.  The cost of vision loss in Canada. 2. Results. , 2011, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[14]  Jonathan Jackson,et al.  How effective is low vision service provision? A systematic review. , 2012, Survey of ophthalmology.

[15]  August Colenbrander,et al.  Assessment of functional vision and its rehabilitation , 2010, Acta ophthalmologica.

[16]  H. Taylor.  Eye care for the future: the Weisenfeld lecture. , 2003, Investigative ophthalmology & visual science.

[17]  Shahrokh Valaee,et al.  Anonymous Indoor Navigation System on Handheld Mobile Devices for Visually Impaired , 2012, Int. J. Wirel. Inf. Networks.

[18]  M. Jackson,et al.  Comprehensive vision rehabilitation. , 2015, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[19]  Esther G González,et al.  Plasticity of fixation in patients with central vision loss , 2009, Visual Neuroscience.

[20]  S. Markowitz,et al.  The use of prisms for vision rehabilitation after macular function loss: an evidence‐based review , 2013, Acta ophthalmologica.

[21]  S. Markowitz.  A practice template for low-vision rehabilitation. , 2009, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[22]  A. J. Roman,et al.  Human RPE65 gene therapy for Leber congenital amaurosis: persistence of early visual improvements and safety at 1 year. , 2009, Human gene therapy.

[23]  Mary Hayhoe,et al.  Perceptual Relearning of Complex Visual Motion after V1 Damage in Humans , 2009, The Journal of Neuroscience.

[24]  Gordon E Legge,et al.  Psychophysics of reading XX. Linking letter recognition to reading speed in central and peripheral vision , 2001, Vision Research.

[25]  Jessy D. Dorn,et al.  Interim results from the international trial of Second Sight's visual prosthesis. , 2012, Ophthalmology.

[26]  Rickilyn M Mancil,et al.  Outcomes of the Veterans Affairs Low Vision Intervention Trial (LOVIT). , 2008, Archives of ophthalmology.

[27]  Philip J Rosenfeld,et al.  Ranibizumab for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.

[28]  N. Orzalesi,et al.  The IOL-Vip System: a double intraocular lens implant for visual rehabilitation of patients with macular disease. , 2007, Ophthalmology.

[29]  Gordon E. Legge,et al.  Psychophysics of reading—II. Low vision , 1985, Vision Research.